In the tumor microenvironment, accumulating CD4+CD39+ iTreg expand upon induction by TA, DC products, and selected cytokines and up-regulate CD73, acquiring the capability to utilize ADO for mediating suppression of other immune cells. The gene discussed is NT5E; the disease is neoplasm.